ODI Pharma AB (publ) (NGM:ODI)

Sweden flag Sweden · Delayed Price · Currency is SEK
1.360
+0.060 (4.62%)
At close: Nov 25, 2025
-46.46%
Market Cap31.16M
Revenue (ttm)8.86M
Net Income (ttm)-4.45M
Shares Out18.33M
EPS (ttm)-0.23
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,435
Average Volume7,741
Open1.350
Previous Close1.300
Day's Range1.350 - 1.360
52-Week Range1.000 - 4.000
Beta0.42
RSI59.38
Earnings DateNov 27, 2025

About ODI Pharma AB

ODI Pharma AB (publ), a pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe. It offers dried flowers; and cosmetics products under the Kandol brand. The company was founded in 2018 and is based in Stockholm, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2018
Employees 1
Stock Exchange Nordic Growth Market
Ticker Symbol ODI
Full Company Profile

Financial Performance

In 2025, ODI Pharma AB's revenue was 3.11 million, a decrease of -86.04% compared to the previous year's 22.29 million. Losses were -5.88 million, 934.9% more than in 2024.

Financial Statements

News

There is no news available yet.